Verified earnings results

Aktis Oncology Q3 2026 Earnings Results

Direct answer

Aktis Oncology reported Q3 2026 results on November 12, 2026.

Revenue was 3,905,000. EPS missed the estimate by 9.71%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Aktis Oncology email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 12, 2026
Reported timing
Before the US market opens
EPS estimate
-0.4922
Reported EPS
-0.54
Revenue
3,905,000
EPS surprise
EPS missed the estimate by 9.71%.

Read the frequently asked questions.

When did Aktis Oncology report Q3 2026 earnings?

Aktis Oncology reported on November 12, 2026. The reported timing was before the us market opens.

What is the available EPS estimate for Aktis Oncology?

The verified record provides an EPS estimate of -0.4922.

Has Aktis Oncology reported the Q3 2026 result?

Revenue was 3,905,000. EPS missed the estimate by 9.71%.

Which source supports this Aktis Oncology earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.